www.antimicrobe.org

[Start Page] [Microbes] [HIV Clinical Manual] [Empiric] [Editorial Board]  [Feedback] [Logout]

Antimicrobial Therapy and Vaccines

1

[AntiBActerial Agents] [Antimycobacterial Agents] [ Antifungal agents]

 [ANtiviral Agents] [Antiparasitic Agents]

ctior
I. Antibacterial Agents

Pharmacokinetic and Pharmacodynamic Issues in the Treatment of Bacterial Infectious Diseases    Peggy S. McKinnon, Pharm.D., Susan L. Davis, Pharm.D.  

Aminoglycosides  Richard Quintiliani, Jr., M.D., David Nicolau, Pharm.D., Brian A. Potoski, Pharm.D.

Aztreonam  David S. Burgess, Pharm.D., Ronald G. Hall II, Pharm.D.

Beta-lactam and Beta-lactamase Inhibitor Combinations (Amoxicillin/Clavulanate, Ampicillin/Sulbactam, Ticarcillin/Clavulanate, Piperacillin/Tazobactam)  Peggy S. McKinnon, Pharm.D. Collin Freeman, Pharm.D.

Carbapenems (Biapenem, Ertapenem, Faropenem, Imipenem, Meropenem, Panipenem) [ Douglas N. Fish, Pharm.D.

Cephalosporins  Blair Capitano, Pharm.D., Michael B. Kays, Pharm.D.

Chloramphenicol  Melinda M. Neuhauser, Pharm.D., Susan L. Pendland, Pharm.D.

Clindamycin  Ronda L. Akins, Pharm.D., Elizabeth Coyle, Pharm.D., Matthew E. Levison, M.D., Jan Verhoef, M.D., Ph.D.

Daptomycin   Kerry L. LaPlante, Pharm.D., Michael J. Rybak, Pharm.D.

Fosfomycin  Gary E. Stein, Pharm.D., Daniel H. Havlichek, Jr., M.D.

Fusidic Acid  Keryn J. Christiansen, MBBS

Glycopeptides ( Dalbavancin, Oritavancin, Teicoplanin, Vancomycin)  N. Virgincar, MSc, MD, Alasdair MacGowan, M.D.

Ketolides (Telithromycin, Cethromycin)  George G. Zhanel, Ph.D., Melinda M. Neuhauser, Pharm.D.

Linezolid and Other Oxazolidinones   Brian T. Tsuji, Pharm D., Glenn W. Kaatz, MD, Michael J. Rybak, Pharm.D.

Macrolides  Lutfiye Mulazimoglu, M.D., Paul M. Tulkens, M.D., Françoise Van Bambeke, Pharm.D.

Metronidazole  Brian J. Barnes, Pharm.D., Kenneth C. Lamp, Pharm.D., Melinda K. Lacy, Pharm.D.

Mupirocin  Suzanne F. Bradley, M.D.

Nitrofurantoin   Gary E. Stein, Pharm.D., Daniel H. Havlichek, Jr., M.D.

Penicillins   Sandra L. Preston, Pharm.D., George L. Drusano, M.D.

Polymyxins  Matthew E. Falagas, Argyris Michalopoulos, Nicolaos Choulis

Quinolones  Susan L. Davis, Pharm.D., Melinda M. Neuhauser, Pharm.D., Peggy S. McKinnon, Pharm.D.

Quinupristin/Dalfopristin   Kimberly D. Leuthner, Pharm.D., Jeffrey R. Aeschlimann, Pharm.D., Michael J. Rybak, Pharm.D.

Rifamycins for Nonmycobacterial Infections   Rocsanna Namdar, Pharm.D., Anne B. Morris, M.D., Charles A. Peloquin, Pharm.D.

Sulfonamides   Daniel H. Havlichek, Jr., M.D., Gary E. Stein, Pharm.D.

Tetracyclines and Analogues   Beulah Perdue Sabundayo, Pharm.D., MPH,  Harold C. Standiford, M.D.

Tigecycline  David R.P. Guay, Pharm.D.

Trimethoprim and Trimethoprim-Sulfamethoxazole (Cotrimoxazole )   Fred W. Goldstein, M.D., Gary E. Stein, Pharm.D.

1

II. AntiMycobacterial Agents

Pharmacokinetic and Pharmacodynamic Issues in the Treatment of Mycobacterial Infections   Eric Nuermberger, M.D., Jacques Grosset, M.D.

Cycloserine  Charles A. Peloquin, Pharm.D.

Ethambutol   Milena L. Lewis, M.D.

Ethionamide   Rocsanna Namdar, Pharm.D., Charles A. Peloquin, Pharm.D.

Isoniazid (INH)   William J. Burman, M.D., Charles A. Peloquin, Pharm.D.

Para-Aminosalicyclic Acid   Charles A. Peloquin, Pharm.D.

Pyrazinamide   Leonid Heifets, M.D., Ph.D.

Rifamycins for Mycobacterial Infections   Charles A. Peloquin, Pharm.D., Andrew A. Vernon, M.D., M.H.S.

1

III. ANtifungal Agents

Antifungal Agents: In vitro Susceptibility Testing, Pharmacodynamics, and Prospects for Combination Therapy   Andreas H. Groll, M.D., Hedwig Kolve, Pharm.D.

Amphotericin B   Astrid M.L. Oude Lashof, M.D., Bart-Jan Kullberg, M.D.

Azoles (Clotrimazole, Fluconazole, Itraconazole, Ketoconazole, Miconazole, Voriconazole)   Andreas H. Groll, M.D., Hedwig Kolve, Pharm.D., Thomas J. Walsh, M.D.

Echinocandins (Anidulafungin, Caspofungin, Micafungin)    Alexander Imhof, M.D., Kieren A. Marr, M.D.

Flucytosine   Richard H. Drew, Pharm.D., John R. Perfect, M.D.

Nystatin   John F. Mohr, Pharm.D., Luis Ostrosky-Zeichner, M.D.

1

IV. Antiviral Agents

Optimizing Clinical Pharmacodynamics of HIV-1 Protease Inhibitors with Inhibitory Quotients Gene D. Morse, Pharm.D., Linda Catanzaro, Pharm.D., Edward Acosta, Pharm.D.

Abacavir   Patrick G. Clay, Pharm.D., Ross G. Hewitt, M.D.

Adefovir   Tony Antoniou, Pharm.D., Patrick G. Clay, Pharm.D., Alice L. Tseng, Pharm.D.

Amantadine, Rimantadine, and Related Agents   Frederick G. Hayden, M.D., Fred Y. Aoki, M.D.

Cidofovir   Patty Fan-Havard, Pharm.D., Edward J. Zabawski, Jr, D.O.

Enfuvirtide and Other Fusion Inhibitors   Rami Kantor, M.D., Gene D. Morse, Pharm.D.

Ganciclovir   Judianne C. Slish, Pharm.D., Clyde S. Crumpacker, M.D., Tony Antoniou, Pharm.D.

Influenza Neuraminidase Inhibitors (Oseltamivir and Zanamivir)   Frederick G. Hayden, M.D., Fred Y. Aoki, M.D.

Interferons   Marion G. Peters, M.D., David J. Quan, Pharm.D.

Lamivudine and Emtricitabine   Linda M. Catanzaro, Pharm.D., Richard B. Pollard, M.D., Robert W. Shafer, M.D., Judianne C. Slish, Pharm.D., Aesha D. Alkebulan,  Pharm.D., Gene D. Morse, Pharm.D.

Nonnucleoside Analogues (Delavirdine, Efavirenz, Nevirapine)   Courtney V. Fletcher, Pharm.D., Michael Para, M.D., Susan Swindells, MBBS

Nucleoside Analogues (Acyclovir, Famciclovir, Penciclovir, Valacyclovir)   Linda M. Catanzaro, Pharm.D., Aesha D. Alkebulan,  Pharm.D., Gene D. Morse, Pharm.D.

Nucleoside Analog Reverse Transcriptase Inhibitors (Didanosine, Zalcitabine, Zidovudine)   Margaret A. Fischl, M.D., Linda M. Catanzaro, Pharm.D., Robert W. Shafer, M.D., Gene D. Morse, Pharm.D.

Protease Inhibitors (Amprenavir, Atazanavir, Indinavir, Lopinavir, Nelfinavir, Ritonavir, Saquinavir)   Linda M. Catanzaro, Pharm.D.,  Angela Kashuba, Pharm.D.,  Amanda H. Corbett, Pharm.D. , Robert W. Shafer, M.D., Ross Hewitt, M.D., Edward Acosta, Pharm.D., Gene D. Morse, Pharm.D.

Ribavirin   Ruth E. Berggren, M.D., Patrick G. Clay, Pharm.D., Juan J.L. Lertora, M.D., Ph.D.

Stavudine   Linda M. Catanzaro, Pharm.D., Richard B. Pollard, M.D., Robert W. Shafer, M.D., Aesha D. Alkebulan,  Pharm.D., Gene D. Morse, Pharm.D.

Tenofovir   Tony Antoniou, Pharm.D., Laura Y. Park-Wyllie, Pharm.D., Alice L. Tseng, Pharm.D., Ross G. Hewitt, M.D.

1

V. Antiparasitic Agents

Pharmacokinetic and pharmacodynamic Issues in the Treatment of Parasitic Infections   Geoffrey Edwards, Ph.D. , Sanjeev Krishna, DPhil, FMedSci 

4-Aminoquinolines (Amodiaquine, Chloroquine)   Geoffrey Edwards, Ph.D., Patrick G. Bray, Ph.D., Stephen A. Ward, Ph.D.

Antimonials (Meglumine antimoniat, Sodium stibogluconate)   Robert N. Davidson M.D., DTM&H, Margriet den Boer, Pharm.D.

Artemisinin and Its Derivatives   Kenneth F. Ilett, BPharm., Ph.D., Kevin T. Batty, Ph.D.

Atovaquone and Atovaquone-Proguanil   David B. A. Hutchinson, M.B., B.S., DTM&H, Gerri B. Miller, M.S.

Benzimidazoles (Albendazole, Mebendazole, Thiabendazole, Triclabendazole)   Thomas A. Moore, M.D., James McCarthy, M.D.

Benznidazole   Louis V. Kirchhoff, M.D., M.P.H.

Bithionol   Joyce Primo-Carpenter, B.Sc., Pharm., M.D.

Diloxanide Furoate   Joyce Primo-Carpenter, B.Sc., Pharm., M.D.

Eflornithine   Marc Ouellette, Ph.D., Jacques Pepin, M.D.

Emetine and Dehydroemetine   Joyce Primo-Carpenter, B.Sc., Pharm., M.D.

Folate Antagonists   William M. Watkins, Ph.D., Peter A. Winstanley, M.D.

Furazolidone   Geoffrey Edwards, Ph.D.

Halofantrine   Geoffrey Edwards, Ph.D., Patrick G. Bray, Ph.D., Stephen A. Ward, Ph.D.

Iodoquinol   Joyce Primo-Carpenter, B.Sc. Pharm., M.D.

Ivermectin   James McCarthy, M.D., Timothy M. E. Davis

Levamisole   Joyce Primo-Carpenter, B.Sc., Pharm.D., M.D.

Mefloquine   Timothy M. E. Davis

Melarsoprol   Jacques Pépin, M.D., Marc Ouellette, Ph.D.

Metrifonate   Alexander G.C. Bauer, Geoffrey Edwards, Ph.D.

Niclosamide   Joyce Primo-Carpenter, B.Sc. Pharm., M.D.

Nifurtimox   Louis V. Kirchhoff, M.D., M.P.H.

Nitazoxanide   Geoffrey Edwards, Ph.D.

Oxamniquine   David Overbosch, Geoffrey Edwards, Ph.D.

Pentamidine   Marc Ouellette, Ph.D., Jacques Pépin, M.D.

Piperazine   James McCarthy, M.D.

Piperazine: Diethylcarbamazine   James McCarthy, M.D.

Praziquantel   James S. McCarthy, M.D., Timothy M. E. Davis

Primaquine   Peter J. de Vries, M.D., Ph.D., Teunis A. Eggelte, Ph.D.

Pyrantel Pamoate   Joyce Primo-Carpenter, B.Sc. Pharm., M.D.

Pyrvinium Pamoate   Joyce Primo-Carpenter, B.Sc. Pharm., M.D.

Quinacrine   Joyce Primo-Carpenter, B.Sc. Pharm., M.D.

Quinine and Quinidine   Sanjeev Krishna, DPhil, FMedSci

Suramin   Jacques Pépin, M.D., Marc Ouellette, Ph.D.

1

www.antimicrobe.org

[Start Page] [Microbes] [HIV Clinical Manual] [Empiric] [Editorial Board]  [Feedback] [Logout]

1
Hit Counter